Company Quick10K Filing
Avangrid
10-Q 2020-09-30 Filed 2020-10-30
10-Q 2020-06-30 Filed 2020-07-31
10-Q 2020-03-31 Filed 2020-05-05
10-K 2019-12-31 Filed 2020-03-02
10-Q 2019-09-30 Filed 2019-10-31
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-02
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-11-02
10-Q 2018-06-30 Filed 2018-08-02
10-Q 2018-03-31 Filed 2018-05-03
10-K 2017-12-31 Filed 2018-03-26
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-06-30 Filed 2017-08-01
10-Q 2017-03-31 Filed 2017-05-05
10-K 2016-12-31 Filed 2017-03-10
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-04-01
10-Q 2015-09-30 Filed 2015-12-16
8-K 2021-02-23 Earnings, Regulation FD, Exhibits
8-K 2021-02-15 Officers
8-K 2021-02-02 Officers, Exhibits
8-K 2020-12-29 Off-BS Arrangement
8-K 2020-12-14 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2020-10-20
8-K 2020-10-20
8-K 2020-07-21
8-K 2020-06-25
8-K 2020-06-22
8-K 2020-06-22
8-K 2020-06-11
8-K 2020-04-28
8-K 2020-04-07
8-K 2020-03-18
8-K 2020-03-11
8-K 2020-03-01
8-K 2020-02-25
8-K 2020-02-19
8-K 2019-12-31
8-K 2019-12-12
8-K 2019-12-03
8-K 2019-10-29
8-K 2019-07-23
8-K 2019-06-30
8-K 2019-06-27
8-K 2019-06-05
8-K 2019-05-14
8-K 2019-04-24
8-K 2019-02-19
8-K 2019-02-13
8-K 2018-12-18
8-K 2018-12-03
8-K 2018-10-23
8-K 2018-10-18
8-K 2018-10-09
8-K 2018-09-27
8-K 2018-07-24
8-K 2018-07-19
8-K 2018-06-29
8-K 2018-06-18
8-K 2018-06-13
8-K 2018-06-07
8-K 2018-04-25
8-K 2018-04-23
8-K 2018-03-16
8-K 2018-03-09
8-K 2018-02-20
8-K 2018-02-16
8-K 2018-02-16
8-K 2018-02-15
8-K 2018-01-31

Avangrid Financials

AGR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546 323 0 0 0 0 -854
1 800 Flowers Com (FLWS) 944 42% 13.3 6% 665 336 1,266 534 37 75 1,001
10x Genomics (TXG) 4,805 75% -490.3 -2% 573 151 61 46 -10 -9 4,357
12 Retech (RETC) 0 32% -0.1 -1,385% 1 20 1 0 -15 -15 1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 34 0% 0.4 -5% 164 108 18 0 -8 -8 -3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 19 23 27 7 -3 -1 3
1895 Bancorp of Wisconsin (BCOW) 46,153 12,508.1 -0% 441 383 0 0 -0 4 46,142
1st Constitution Bancorp (FCCY) 165 0% 4.4 1% 1,343 1,204 0 0 14 33 144
1st Franklin Financial (FFC) 4 -0.6 7% 905 645 0 0 62 80 -46
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200 7.9 1% 6,691 5,858 0 0 70 136 1,073
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 2 0 0 -2 -2 0
21Vianet Group (VNET) 6,005 0% 11,151 5,788 0 0 0 0 3,344
22nd Century (XXII) 302 1% -14.1 -36% 62 7 26 0 -22 -21 302
1Life Healthcare (ONEM)

Balance Sheet ($MM)2015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1,05042740339618291303627414057404338172108
Accounts Receivable7239749648949561,1191,1179849431,0401,1139861,0601,1421,2641,009966
Inventory
PP&E17,02920,69820,83021,12421,54821,79722,29022,68222,66922,75722,91723,12523,45923,55524,37324,750
Assets24,39730,74330,53930,41130,60931,30931,39631,48531,92131,67131,48331,37631,75532,16732,60833,14133,547
Accounts Payable5768303
Long-Term Debt2,9674,9854,6854,6754,5865,2044,8325,0805,0345,7995,3745,6235,6195,9525,8126,6566,950
Liabilities11,75015,67715,41515,34615,55816,18716,14416,24416,70416,57516,16415,90816,30016,76417,15217,59218,029
Stockholders' Equity12,63115,05315,11115,05215,03815,10915,23915,22715,20215,07715,17115,13515,12815,10415,15815,13515,150
Income Statement ($MM)2015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,1531,4911,5331,5461,6651,8421,4001,487
Cost of Revenue
Gross Profit
R&D
SG&A
Tax56-69104172535010344324722729412933
Net Income5496212102109207239120100-77244110134119217110150
Cash Flow ($MM)2015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating398397511308345441484397441597334315502427
Cash Investing-905-201-336-328-662-514-531-622-674-323-427-526-926-704
Cash Financing-116-220-182-1942241254217245-27576206558213